Skip to main content
S 1133 117th Congress Senate Health Advanced technology and technological innovations Cardiovascular and respiratory health Government information and archives Health information and medical records Health programs administration and funding Health promotion and preventive care Health technology, devices, supplies Medical research Medical tests and diagnostic methods Photography and imaging Research administration and funding

Cardiovascular Advances in Research and Opportunities Legacy Act

Introduced: April 15, 2021 Introduced by: McConnell, Mitch Republican · Kentucky See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 117th Congress ended
It never became law before the 117th Congress (2021–2022) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 15, 2021
Introduced in Senate
Apr 15, 2021
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S1984; text: CR S1985)
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Cardiovascular Advances in Research and Opportunities Legacy Act

This bill expands research on valvular heart disease and its treatment. This disease is caused by damage to or disease affecting any valve that controls blood flow in the heart.

The National Institutes of Health must consult with the National Heart, Lung, and Blood Institute to conduct or support research on the disease, including on mitral valve prolapse. This occurs when the valve between the chambers of the left side of the heart seals improperly.

The Centers for Disease Control and Prevention (CDC) must develop best practices to treat valvular heart disease. The CDC may also carry out other projects to increase awareness of and reduce deaths from the disease.

What's happening now April 15, 2021

Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S1984; text: CR S1985)

 Related & companion bills 1
  • HR 1193 Related bill Cardiovascular Advances in Research and Opportunities Legacy Act
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Cosponsors 2
All 2 Republican 1
R
Daines, Steve
Montana · Dec 9, 2021
Sinema, Kyrsten
· Apr 15, 2021
Cite this page click to expand
APA
U.S. Congress. (2026). S. 1133: Cardiovascular Advances in Research and Opportunities Legacy Act. 117th Congress. Open America. https://openamerica.io/bill/117-S-1133/
MLA
"S. 1133: Cardiovascular Advances in Research and Opportunities Legacy Act." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-S-1133/.
Bluebook (legal)
S. 1133, 117th Cong. (2026), https://openamerica.io/bill/117-S-1133/.
Markdown link
[S. 1133: Cardiovascular Advances in Research and Opportunities Legacy Act](https://openamerica.io/bill/117-S-1133/)
Report a problem